ROX index (high-flow nasal oxygen)

Predicts success or failure of high-flow nasal oxygen in hypoxaemic respiratory failure

Sources last checked: 2026-10-13

ROX index (high-flow nasal oxygen)

Predicts success or failure of high-flow nasal oxygen in hypoxaemic respiratory failure

Fill in every field to see the result.

Derived and validated in pneumonia patients on high-flow nasal oxygen (Spain and France). Thresholds depend on the time since HFNO start; a single value never replaces clinical assessment of work of breathing.

Source: Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med 2019;199(11):1368-1376.Open

Interpretation

< 2.85 — high risk of HFNO failureBelow the failure threshold at every time point studied (2 h < 2.85, 6 h < 3.47, 12 h < 3.85). In Roca 2019, values below these thresholds predicted HFNO failure (need for intubation).
2.85–3.84 — check the time pointBelow the failure threshold if measured at 6 h (< 3.47) or 12 h (< 3.85) after starting HFNO; indeterminate at 2 h.
3.85–4.87 — indeterminateNeither the success nor the failure threshold reached; the result is indeterminate at this time point.
≥ 4.88 — lower risk of intubationAssociated with HFNO success when measured at 2, 6 or 12 h.

What is the ROX index (high-flow nasal oxygen)?

The ROX index is the ratio of SpO₂/FiO₂ to respiratory rate. Roca and colleagues developed it in Spain for patients with pneumonia on high-flow nasal oxygen and validated it in a multicentre cohort in Spain and France, where values ≥ 4.88 at 2, 6 or 12 hours predicted success and low time-specific values predicted the need for intubation.

When to use it

  • Serial assessment of patients with hypoxaemic respiratory failure on high-flow nasal oxygen
  • Estimating the risk of HFNO failure (need for intubation) at the time points studied by Roca 2019
  • Documenting response to HFNO at standard time points (2, 6, 12 h)

When not to use it

  • Hypercapnic respiratory failure (e.g. COPD exacerbation) — not the validation population
  • Patients on low-flow oxygen or non-invasive ventilation
  • When SpO₂ is unreliable (poor perfusion, dark skin pigmentation with some oximeters, carbon monoxide)

How it is calculated

ROX = (SpO₂ % ÷ FiO₂ as fraction) ÷ respiratory rate

Clinical pearls and limitations

  • Derived and validated in pneumonia patients on high-flow nasal oxygen (Spain and France). Thresholds depend on the time since HFNO start; a single value never replaces clinical assessment of work of breathing.
  • SpO₂/FiO₂ carried more weight than respiratory rate in the original analysis.
  • Failing patients showed a smaller rise in ROX over the first 12 hours, so the trend matters as much as one value.
  • SpO₂ values above 97 % flatten the oxyhaemoglobin curve and make SpO₂/FiO₂ less informative.
  • A reassuring ROX does not override clinical signs of exhaustion such as accessory muscle use or paradoxical breathing.

Frequently asked questions

What is a good ROX index?

A value ≥ 4.88 at 2, 6 or 12 hours after starting HFNO was associated with a lower risk of intubation.

When does ROX predict HFNO failure?

Values below 2.85 at 2 hours, below 3.47 at 6 hours and below 3.85 at 12 hours were highly specific predictors of failure.

How is ROX calculated?

Divide SpO₂ (%) by FiO₂ as a fraction, then divide by the respiratory rate. For SpO₂ 92 %, FiO₂ 0.6 and RR 30: (92 / 0.6) / 30 = 5.1.

Can ROX be used in COVID-19?

Several cohorts applied it in COVID-19 pneumonia with broadly similar thresholds, but the original validation was in bacterial and viral pneumonia before the pandemic.

Evidence and guidelines

  1. Primary source: Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med 2019;199(11):1368-1376.
  2. Roca O, Messika J, Caralt B, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: the utility of the ROX index. J Crit Care 2016;35:200-205 (derivation).

Have a follow-up question?

Medelix answers clinical questions from current guidelines and studies — every statement with its source.

Ask Medelix about the ROX index (high-flow nasal oxygen)

Related calculators

Embed this calculatorFree to use on your website, intranet or teaching page. Copy the code below.
<iframe src="https://medelix.ai/en/embed/rox-index" title="ROX index (high-flow nasal oxygen) – Medelix" width="100%" height="620" style="border:0;max-width:720px" loading="lazy"></iframe> <p><a href="https://medelix.ai/en/calculators/rox-index">ROX index (high-flow nasal oxygen) calculator by Medelix</a></p>

For healthcare professionals and medical students. These tools support, and do not replace, clinical judgement. Always check results against the original source and your local protocols.